Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed CFO
Quarterly results
CFO resigned
CC transcript
Appointed director

OSIRIS THERAPEUTICS, INC. (OSIR) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/17/2019 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Articles of Incorporation of the Company",
"Amended and Restated Bylaws of the Company",
"Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc"
03/12/2019 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Smith & Nephew plc, Smith & Nephew Consolidated, Inc., Papyrus Acquisition Corp. and Osiris Therapeutics, Inc"
03/12/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "[email protected]",
"Letter from Samson Tom, President and Chief Executive Officer of Osiris Therapeutics, Inc., to Employees of Osiris Therapeutics, Inc.",
"Frequently Asked Questions"
11/26/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/08/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "Summary Notice of Pendency and Proposed Settlement of Shareholder Derivative Actions"
09/17/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "[email protected]"
09/11/2018 8-K Resignation/termination of a director
07/10/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/02/2018 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Form of Indemnification and Advancement of Expenses Letter Agreement"
06/28/2018 8-K Submission of Matters to a Vote of Security Holders
06/04/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "[email protected]"
05/10/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/19/2018 8-K Other Events
02/08/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/06/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/14/2017 8-K Resignation/termination of a director
12/05/2017 8-K Other Events
06/26/2017 8-K Quarterly results
05/31/2017 8-K Form 8-K - Current report
05/19/2017 8-K Form 8-K - Current report
05/17/2017 8-K Form 8-K - Current report
03/27/2017 8-K Form 8-K - Current report
03/10/2017 8-K Form 8-K - Current report
02/10/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "[email protected]"
01/31/2017 8-K Form 8-K - Current report
01/12/2017 8-K Form 8-K - Current report
12/02/2016 8-K Form 8-K - Current report
11/21/2016 8-K Form 8-K - Current report
10/14/2016 8-K Other Events
10/07/2016 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
10/06/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Osiris Therapeutics Announces Appointment of Alberto Avendano, M.D. as Chief Medical Officer COLUMBIA, Md. — October 6, 2016"
09/16/2016 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Osiris Provides Update Regarding NASDAQ Listing Status"
08/17/2016 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Osiris Provides Update Regarding NASDAQ Listing Matters COLUMBIA, Md. — August 17, 2016 - Osiris Therapeutics, Inc. today provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ Stock Market . As previously disclosed, on each of March 17, 2016 and May 12, 2016 the Company received a notification from NASDAQ indicating that, as a result of the Company not timely filing with the Securities and Exchange Commission its Annual Report on Form 10-K for the year ended December 31, 2015 and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2016 , respectively, the Company failed to comply with the periodic filing requirements in NASDAQ Listing Rule 5250 . On August 12, 2016, the Company received an anticipated letter from NASDAQ noting that th..."
06/29/2016 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Letter Agreement, between Osiris Therapeutics, Inc. and David A. Dresner"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy